title: Aggressive multiple modality therapy for varicella-associated purpura fulminans.
authors.forename: D P
authors.initials: DP
authors.lastname: Busuttil
authors.forename: C R
authors.initials: CR
authors.lastname: Hay
authors.forename: M A
authors.initials: MA
authors.lastname: Lewis
authors.forename: R F
authors.initials: RF
authors.lastname: Wynn
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D002644:Chickenpox / Q000150:complications* / Q000628:therapy; D002648:Child; D003131:Combined Modality Therapy; D003450:Cryoglobulins / Q000627:therapeutic use; D005165:Factor V; D006493:Heparin / Q000627:therapeutic use; D014645:Herpesvirus 3, Human; D006801:Humans; D011695:IgA Vasculitis / Q000235:genetics / Q000628:therapy* / Q000821:virology*; D008297:Male; D010951:Plasma Exchange; D018455:Protein S Deficiency / Q000821:virology*; D011516:Prothrombin / Q000235:genetics
chemical_list: D000925:Anticoagulants; D003450:Cryoglobulins; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin; D006493:Heparin